Sign up to save your podcasts
Or
Share Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?
PARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen? Credit available for this activity expires: 03/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989483?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
PARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen? Credit available for this activity expires: 03/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989483?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
131 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
323 Listeners
This Week in Cardiology
865 Listeners
JAMA Clinical Reviews
493 Listeners
AFP: American Family Physician Podcast
696 Listeners
One-on-One with Eric Topol
18 Listeners
Mayo Clinic Talks
276 Listeners
Frankly Speaking About Family Medicine
253 Listeners
The Curbsiders Internal Medicine Podcast
3,318 Listeners
Emergency Medical Minute
258 Listeners
JAMA Medical News
87 Listeners
Core IM | Internal Medicine Podcast
1,086 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Medicine and the Machine
59 Listeners
Keeping Current CME
25 Listeners
Ninja Nerd
286 Listeners